BOSTON/NEW YORK - Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.
- Power company Dynegy Inc said on Friday that it would buy coal and gas power plants for $6.25 billion to increase its presence in two less regulated eastern U.S. markets, sending its shares up as much as 22.5 percent.
NEW YORK - Neustar Inc, a company which helps North American telecommunication carriers route calls and text messages, is considering a potential sale amid interest from private equity firms, according to people familiar with the matter.
LONDON - London Stock Exchange Group Plc is raising 938 million pounds ($1.6 billion) in its first rights issue of new stock to part fund the acquisition of U.S. indexes group Frank Russell.
WASHINGTON - U.S. communications regulators on Friday asked Comcast Corp for additional details about its video and broadband operations, including its web traffic management practices, to review the company's proposed merger with Time Warner Cable Inc .
TORONTO - Canadian medical marijuana producer OrganiGram Inc is set to go public on Monday, its chief executive said, the second such firm to list on the venture exchange next week, highlighting investor appetite for a high-growth industry.
- American Securities LLC-backed auto parts maker Metaldyne Performance Group Inc filed with U.S. regulators for an initial public offering of its common shares.
SINGAPORE/ZURICH - Royal Bank of Scotland plc might split its international private bank into separate European and Asian divisions to attract Asian buyers who have the financial muscle for a deal but are reluctant to take on European client risk.
FRANKFURT - Airbus is considering a sale of its 49 percent stake in submarine supplier Atlas Elektronik as part of a reshuffle of its military business, German newspaper Die Welt reported on its website on Friday, citing industry sources.
ZURICH - Swiss drugs industry supplier Lonza Group AG is courting the financial backers of biotech firms to help secure a steady stream of projects and offset some of the volatility of outsourced production contracts, a senior executive said.
- Finance: Apollo in talks to buy Portuguese insurer from BES successor
- Technology: Rocket Internet and Zalando to unveil listing plans in September: sources
- Healthcare: Ackman, other shareholders ask Allergan to call special meeting
- Consumer: Exclusive: Ouya scores Xiaomi partnership to take games to China
- Energy: Germany clears $6.9 billion RWE unit sale to Russian investor
- Industrials: Germany approves RWE unit sale amid Russia tensions
- M&A: Deals of the day- Mergers and acquisitions
- Bankruptcy: UPDATE 2-Detroit water board OKs repurchase of $1.5 bln tendered bonds
- IPOs: UPDATE 3-LSE unveils $1.6 bln rights issue for Frank Russell deal
- Private Capital: UPDATE 1-Auto parts maker Metaldyne Performance files for IPO
- Hedge Funds: Funds could face market curbs after lobbying backfires
- Regulatory: UPDATE 3-Obama tech policy maven moves to Silicon Valley role
Free Deals Newsletter
- Alibaba IPO - The Timing Couldn't Be Any Better - Investorplace.com
- Exclusive: Phone registry company Neustar weighs sale - sources - Reuters
- US asks Comcast for more data to review Time Warner Cable merger - Reuters
- Madison Square Garden Pushed by Hedge Fund to Boost Value - Bloomberg
- New PlayStation Flash Sale: 19 Games, $10 Each - IGN
- IPO-Bound E-Commerce Giant Rocket Internet Consolidates, Holtzbrink Takes ... - TechCrunch
- 4 Tips For Coping With The Emotional Cost Of Bankruptcy - Forbes
- Deals of the day- Mergers and acquisitions - Reuters